EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Bdnf mRNA‐LNP Drives Nasal Epithelial BDNF Production and Improves Cognition in Aged and Alzheimer's Disease Mouse Models

Maria Bergamasco iD, Hannah Scarborough iD, Anna Ponta iD, Teleri Clark, Scott B Cohen, Lipin Loo iD, Kazuma Fujikake iD, Rebecca Carr, R M Damian Holsinger iD, G Gregory Neely iD

Advanced Science · 2026-11-18

DOI: 10.1002/advs.78225 ↗

At a glance

Journal article in Advanced Science, published online on 2026-11-18. Written by Maria Bergamasco and 9 co-authors. Institution: School of Life and Environmental Sciences and the Charles Perkins Centre, the University of Sydney, Sydney, New South Wales, Australia. 96 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Health and Medical Research council (NHMRC).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Messenger RNA (mRNA) therapeutics have rapidly emerged as a transformative approach for treating a range of health challenges. Accelerated by the success of mRNA‐lipid nanoparticle (LNP) vaccines during the COVID‐19 pandemic, this platform holds promise beyond immunisation for the transient expression of therapeutic proteins in targeted tissues. Despite this promise, non‐invasive delivery of mRNA‐encoded cargo to the brain remains a challenge, as most peptide drugs do not pass the blood‐brain barrier. Here, we present the development of an intranasal mRNA‐LNP therapeutic that drives production of neurotrophic factors in the nasal epithelium and delivery of the encoded protein to the brain. As a proof of concept, we demonstrate that intranasal delivery of mRNA encoding the neurogenic factor BDNF (Brain Derived Neurotrophic Factor) enhances memory performance in both aged mice and a transgenic mouse model of Alzheimer's disease. This approach offers a promising platform for delivering therapeutic proteins to the brain and opens new avenues for treating age‐related and neurodegenerative disorders.

Subjects

Author keywords

BDNFLNPcognitive declineintranasal deliverymRNA

Authors and institutions

  • School of Life and Environmental Sciences and the Charles Perkins Centre, the University of Sydney, Sydney, New South Wales, Australia.
  • Children's Medical Research Institute, Faculty of Medicine and Health, University of Sydney, Westmead, New South Wales, Australia.
  • Laboratory of Molecular Neuroscience and Dementia, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.
  • Neuroscience, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.

ORCID profiles: Maria Bergamasco, Hannah Scarborough, Anna Ponta, Lipin Loo, Kazuma Fujikake, R M Damian Holsinger, G Gregory Neely

Funding

  • National Health and Medical Research council (NHMRC)

Cite

APA

Bergamasco, M., Scarborough, H., Ponta, A., Clark, T., Cohen, S. B., Loo, L., Fujikake, K., Carr, R., Holsinger, R. M. D., & Neely, G. G. (2026). Bdnf mRNA‐LNP Drives Nasal Epithelial BDNF Production and Improves Cognition in Aged and Alzheimer's Disease Mouse Models. Advanced Science. https://doi.org/10.1002/advs.78225

Vancouver

Bergamasco M, Scarborough H, Ponta A, Clark T, Cohen SB, Loo L, et al. Bdnf mRNA‐LNP Drives Nasal Epithelial BDNF Production and Improves Cognition in Aged and Alzheimer's Disease Mouse Models. Advanced Science. 2026. doi:10.1002/advs.78225

BibTeX
@article{Bergamasco2026,
  author = {Bergamasco, Maria and Scarborough, Hannah and Ponta, Anna and Clark, Teleri and Cohen, Scott B and Loo, Lipin and Fujikake, Kazuma and Carr, Rebecca and Holsinger, R M Damian and Neely, G Gregory},
  title = {Bdnf mRNA‐LNP Drives Nasal Epithelial BDNF Production and Improves Cognition in Aged and Alzheimer's Disease Mouse Models},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.78225}
}
Start for free →